ARTICLE | Company News
ComGenex, Echelon cancer deal
February 1, 2005 8:00 AM UTC
Echelon (Salt Lake City, Utah) acquired exclusive rights to develop, manufacture and market certain PI3 kinase inhibitor cancer candidates discovered through a joint discovery program with ComGenex (B...